Nathan L. Mata
Chief Scientific Officer · BELITE BIO, INC
- 2026
- May 8, 2026
- 16
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nathan L. Mata files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yu-Hsin Lin - $20.82M in BLTE purchases and sales in the last 12 months
- Hao-Yuan Chuang - $14.00M in BLTE purchases and sales in the last 12 months
- Hendrik Peter Scholl - $2.94M in BLTE purchases and sales in the last 12 months
- Wan-Shan Chen - $198K in BLTE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nathan L. Mata?
Nathan L. Mata is a corporate insider, tracked as Chief Scientific Officer of BELITE BIO, INC (BLTE). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Nathan L. Mata last file a Form 4?
The most recent primary Form 4 on record is dated 8 May 2026, one of 16 filings going back to 2026.
Has Nathan L. Mata been buying or selling stock?
Recorded transactions: 0 open-market purchases and 91 open-market sales ($2.36M) across all tracked filings.
